Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate (vol 2018, 1374821, 2018)

被引：2
|
作者：
Rabe, Thomas [1 ]
Saenger, Nicole [2 ]
Ebert, Andreas D. [3 ]
Roemer, Thomas [4 ]
Tinneberg, Hans-Rudolf [5 ]
De Wilde, Rudy Leon [6 ]
Wallwiener, Markus [7 ]
机构：
[1] Deutsch Gesell Gynakol Endokrinol & Fortpflanzung, Munich, Germany
[2] Klinikum Frauenheilkunde & Geburtshilfe, Frankfurt, Germany
[3] Praxis Frauengesundheit Gynakol & Geburtshilfe, Berlin, Germany
[4] Evangel Krankenhaus Weyertal gGmbH, Cologne, Germany
[5] Univ Klin Giessen & Marburg, Campus Giessen, Giessen, Germany
[6] Univ Klin Gynakolog, Pius Hosp Oldenburg, Klin Frauenheilkunde Geburtshilfe & Gynakol Onkol, Oldenburg, Germany
[7] Univ Frauenklin Heidelberg, Heidelberg, Germany
来源：
BIOMED RESEARCH INTERNATIONAL | 2018年 / 2018卷
关键词：
D O I：
10.1155/2018/6124628
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 34 条
  • [1] Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate
    Rabe, Thomas
    Saenger, Nicole
    Ebert, Andreas D.
    Roemer, Thomas
    Tinneberg, Hans-Rudolf
    De Wilde, Rudy Leon
    Wallwiener, Markus
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [2] Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate
    Donnez, Jacques
    Donnez, Olivier
    Dolmans, Marie-Madeleine
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (12) : 1679 - 1686
  • [3] Endometrial Morphology After Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator, Ulipristal Acetate
    Williams, Alistair R. W.
    Bergeron, Christine
    Barlow, David H.
    Ferenczy, Alex
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (06) : 556 - 569
  • [4] Pretreatment of Uterine Fibroids Using a Selective Progesterone Receptor Modulator - Ulipristal Acetate
    Thompson, M.
    Wong, M.
    Opemuyi, I.
    Madipola, N.
    Ramadan, T.
    Nnochiri, A.
    Guttman, J.
    20TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2015, : 205 - 210
  • [5] Selective Progesterone Receptor Modulator(ulipristal acetate - a new option in the pharmacological treatment of uterine fibroids in women
    Szamatowicz, Marian
    Kotarski, Jan
    GINEKOLOGIA POLSKA, 2013, 84 (03) : 219 - 222
  • [6] Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids
    Szydlowska, Iwona
    Marciniak, Aleksandra
    Nawrocka-Rutkowska, Jolanta
    Ryl, Aleksandra
    Starczewski, Andrzej
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (03)
  • [7] The potential of selective progesterone receptor modulators for the treatment of uterine fibroids
    Bestel, Elke
    Donnez, Jacques
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (01) : 79 - 92
  • [8] Medical treatment with ulipristal acetate for uterine fibroids: Will it be resurrected?
    Liu, James H.
    FERTILITY AND STERILITY, 2021, 116 (01) : 80 - 80
  • [9] Selective progesterone receptor modulators (SPRMs) for uterine fibroids
    Murji, Ally
    Whitaker, Lucy
    Chow, Tiffany L.
    Sobel, Mara L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (04):
  • [10] Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
    Szydlowska, Iwona
    Grabowska, Marta
    Nawrocka-Rutkowska, Jolanta
    Kram, Andrzej
    Piasecka, Malgorzata
    Starczewski, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
1234